Thyroid cancer ranks first in the growth trend of female incidence in recent years. Why is this high-incidence cancer called “lazy cancer”?

At present, thyroid cancer is showing a high incidence trend worldwide. The latest statistics from the National Cancer Center in 2022 show that among women, thyroid tumors have the highest incidence in recent years. How malignant is thyroid cancer? Will it affect the patient’s lifespan?

To answer the above questions, we must first understand the pathological types of thyroid cancer. The pathological types of thyroid cancer are mainly papillary carcinoma, follicular carcinoma, medullary carcinoma and anaplastic carcinoma. Among them, papillary thyroid cancer is the most common, and most of the thyroid cancer patients admitted in outpatient clinics belong to this type.

Papillary thyroid carcinoma can be further divided into three subtypes, including traditional subtype papillary carcinoma, follicular subtype papillary carcinoma, and tall cell subtype papillary carcinoma. The prognosis of patients with these three different subtypes will be different, but in general papillary thyroid cancer has a low degree of malignancy, a slow development rate, and a relatively good prognosis, so it is also called “lazy cancer”.

For patients with papillary thyroid cancer, what should they do? First of all, keep a relaxed state of mind and don’t worry too much. Positive and optimistic emotions are also conducive to the diagnosis and treatment of diseases and the recovery of health.

Second, go to professional medical institutions for appropriate treatment. After the pathological diagnosis of papillary thyroid cancer, a professional physician will further evaluate the patient to determine whether it is suitable for surgical treatment. At present, surgery is a better treatment method for patients with thyroid cancer. The lesion can be removed, and the doctor will give a professional TSH suppression therapy (thyroid hormone suppression therapy) after surgery to improve the prognosis of the patient.

Thirdly, it is very necessary for patients to have regular follow-up of B-ultrasound and thyroid function, so that the effect after treatment can be known in time, which will help patients obtain better treatment prognosis. Under the guidance of professional doctors, receiving regular treatment, I believe that patients with papillary thyroid cancer can face the disease calmly and no longer “talk about cancer discoloration”.

*Wenhui’s exclusive manuscript, please indicate the source when reprinting.